-
Product Insights
Wilms' Tumor (Nephroblastoma) - Drugs In Development, 2024
Empower your strategies with our Wilms' Tumor (Nephroblastoma) – Drugs In Development, 2024 report and make more profitable business decisions. Wilms' Tumor also known as Nephroblastoma is a type of cancer in one kidney commonly seen in children and is the most common cancer in children around 3-5 years of age and rarely observed in adults. Although the exact cause is idiopathic genetic alterations in WT1, CTNNB1, and WTX, TP53 and MYNC are believed to cause this. Tumor originates from the...
-
Product Insights
Bone Tumor - Drugs In Development, 2024
Empower your strategies with our Bone Tumor – Drugs In Development, 2024 report and make more profitable business decisions. Bone Tumor or bone cancer affecting any bone in the body. Most of the bone cancers are benign while some are malignant or cancerous. This occurs when bone cells divide uncontrollably. Osteosarcoma, Ewing sarcoma, chondrosarcoma are the types of sarcomas. Most commonly occurs in children than in adults. Etiology is idiopathic. Pain in bones, swelling, fatigue, fever, weight loss are some common...
-
Product Insights
Ductal Carcinoma - Drugs In Development, 2024
Empower your strategies with our Ductal Carcinoma – Drugs In Development, 2024 report and make more profitable business decisions. Ductal Carcinoma is early stage of breast cancer where the ductal cells of the breast tissue tend to multiply or grow uncontrollably without any evidence of metastatic. If not treated in initial stages, this could be invasive. Ductal carcinoma is represented in 4 different stages, pre invasive, non-invasive, ductal intraepithelial neoplasia, intra ductal cancer. In invasive form spread of cancer cells into...
-
Product Insights
Plasma Cell Neoplasm - Drugs In Development, 2024
Empower your strategies with our Plasma Cell Neoplasm – Drugs In Development, 2024 report and make more profitable business decisions. Plasma Cell Neoplasm or plasma cell cancer is a group of diseases involving B-cells. These tumors are found in soft tissues that can be malignant or benign. Multiple Myeloma, lymphoplasmacytic lymphoma, plasmacytoma are the types of plasma cell cancers. Of all three multiple Myeloma is the most common and aggressive form. Age, chronic infection, exposure to radiation, hereditary factors, are some...
-
Product Insights
Post-Transplant Lymphoproliferative Disorder - Drugs In Development, 2024
Empower your strategies with our Post-Transplant Lymphoproliferative Disorder – Drugs In Development, 2024 report and make more profitable business decisions. Post-Transplant Lymphoproliferative Disorder is a complication of organ transplantation and is a life-threatening condition. Infections occurring because of low immunity like EBV (Epstein-Barr virus) also known common cause. Symptoms are non-specific and varies from one another but most commonly fever, malaise, weight loss are seen. EBV tests, CBP, Urine analysis, CT-scan, PET scan are the common diagnostics methods. As Immunosuppressants are...
-
Product Insights
Tenosynovial Giant Cell Tumor - Drugs In Development, 2024
Empower your strategies with our Tenosynovial Giant Cell Tumor – Drugs In Development, 2024 report and make more profitable business decisions. Tenosynovial Giant Cell Tumors are non-cancerous or benign form of tumors arising from the synovium of the joints or in the soft tissues. Genetically caused due to mutations in the stromal cells of synovium and is divided into three different types as Giant cell tumors of the synovium, Giant cell tumors of the tendon sheath, Giant cell tumors of the...
-
Product Insights
Acute Promyelocytic Leukemia - Drugs In Development, 2024
Empower your strategies with our Acute Promyelocytic Leukemia – Drugs In Development, 2024 report and make more profitable business decisions. Acute Promyelocytic Leukemia is an aggressive blood cancer affecting the white blood cells known as promyelocytes which are immature white blood cells. It is characterized by thrombocytopenia (low platelets) resulting in thrombosis, excess bleeding, and anemia. It is a sub type of AML (acute myeloid leukemia) and is a medical emergency condition. Infections, bruises, bleeding are common symptoms and when examined...
-
Product Insights
Giant Cell Tumor Of Bone - Drugs In Development, 2024
Empower your strategies with our Giant Cell Tumor Of Bone – Drugs In Development, 2024 report and make more profitable business decisions. Giant Cell Tumor is a common benign tumor (non-cancerous) that grows at the long bones typically femur and tibia and knee joints. It is observed commonly in age groups 20-40 years. As name reflects the tumor cells appears giant in size. It can be aggressive and may spread to the surrounding bones in rare cases. Cause is unknown. But...
-
Product Insights
Paraganglioma (Glomus Jugulare Tumor) - Drugs In Development, 2024
Empower your strategies with our Paraganglioma (Glomus Jugulare Tumor) – Drugs In Development, 2024 report and make more profitable business decisions. Abnormal growth of chromaffin cells, a type of nerve cell found throughout the body leads to paraganglioma also known as glomus jugulare tumor. It is a rare form of neuroendocrine tumor. These tumors can be found in adrenal glands or outside of it especially in carotid artery. Cause is idiopathic. Headache, high blood pressure, faster pulse rate, sweating is some...
-
Product Insights
Paranasal Sinus And Nasal Cavity Cancer - Drugs In Development, 2024
Empower your strategies with our Paranasal Sinus And Nasal Cavity Cancer – Drugs In Development, 2024 report and make more profitable business decisions. Malignant cells in the tissues of paranasal sinuses and nasal cavity results in paranasal sinus and nasal cavity cancer. It is rare type of cancer categorized into five stages (stage 0- stage 4) and of different types like adenocarcinoma, squamous cell carcinoma, melanoma, lymphoma, sarcoma etc. It can be metastasis in nature. Exposure to chemicals, dust, age, infections...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.